The same holds true for changes in tumor cell expression profiles, including downregulation of genes coding for chemokines such as CXCL12. We could not validate this finding at the protein level but our preliminary findings on changes in myeloma cells and the TME provide potential explanations for this discrepancy. This evidence concerns the gene CXCL12 and neoplasm.